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TACEEtoposide is a widely used anticancer drug in the treatment of different tumors. Etoposide is known to
activate a wide range of intracellular signals, which may in turn induce cellular responses other than
apoptosis. ADAM10 and TACE/ADAM17 belong to a family of transmembrane extracellular metalloprotei-
nases involved in paracrine/juxtacrine regulation of many signaling pathways. The aim of this work was to
evaluate if etoposide induces upregulation of ADAM10 or TACE/ADAM17 in two cell lines (GC-1 and GC-2)
derived from male germ cells. Results showed that etoposide induced apoptosis in a dose–response manner
in both GC-1 and GC-2 cells. Apoptosis started to increase 6 h after etoposide addition in GC-2 cells, whereas
the same was observed 18 h after addition to the GC-1 cells. Protein and mRNA levels of ADAM10 and TACE/
ADAM17 increased 18 h after etoposide was removed from the GC-1 cells. In GC-2 cells, the protein levels of
both proteins increased 12 h after etoposide was removed. ADAM10 mRNA increased after 3 h and then
steadily decreased up to 12 h after removal, whereas TACE/ADAM17 mRNA decreased after etoposide
removal. Finally, apoptosis was prevented in GC-1 and GC-2 cells by the addition of pharmacological
inhibitors of ADAM10 and TACE/ADAM17 to the culture medium of etoposide-treated cells. Our results show
for the ﬁrst time that etoposide upregulates ADAM10 and TACE/ADAM17 mRNA and protein levels. In
addition, we also show that ADAM10 and TACE/ADAM17 have a role in etoposide-induced apoptosis.ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Etoposide (VP-16) is a podophyllotoxin semi-derivative agent
used in a variety of chemotherapeutic treatments. Previous reports
have proposed that etoposide's activity is mediated by its interaction
with topoisomerase II, an ATP-dependent nuclear enzyme that
regulates DNA topology by transiently breaking and joining double-
stranded DNA [1]. It has been shown that etoposide induces apoptosis,
both p53-dependent and -independent, in several cultured cancer cell
lines and is widely used in different protocols for testicular cancer [2].
In addition, etoposide induces a number of intracellular responses
such as activation of protein kinase C delta (PKCδ), increase in reactive
oxygen species (ROS) and activation of p38 MAPK [3–6]. Thus, it is
possible that etoposide triggers several cellular responses, besides
apoptosis, particularly in those cancer cells resistant to this drug or in
non-cancerous viable cells. In addition, it has been shown that
etoposide regulates the levels of matrix metalloproteinase 2 (MMP2)
and activates the transforming growth factor-β1/p38/Smad3 signal-ing pathway in bone marrow stromal cells, but these responses seem
not to be related with its pro-apoptotic activity [7,8].
Several signaling molecules, such as epidermal growth factor
(EGF) and ﬁbroblast growth factor (FGF), are synthesized as
transmembrane proteins; then, upon speciﬁc cellular signals, the
extracellular domains of these proteins are shed from the cell surface
and their biological functions are executed in target cells [9]. A family
of transmembrane metalloproteinases known as “a disintegrin and
metalloprotease” (ADAM) proteins is a key component in protein
ectodomain shedding [10]. ADAMs play a role in diverse biological
processes mainly by regulating paracrine/juxtacrine cell-to-cell
communication [9,11]. ADAMs are type 1 transmembrane proteins
of approximately 70 to 90 kDa. They feature a common modular
ectodomain structure, and a prodomain that is cleaved off in the
trans-Golgi network by protein convertases. ADAM10 and the TNF-
alpha convertase (TACE or ADAM17) are the most studied since they
have relevant roles in the shedding of the ectodomain of several
membrane-bound EGFR ligands such as neuregulin, EGF and devel-
opmental regulatory proteins such as the NOTCH receptor and pro-
TNF-alpha [9,11].
In a given cell type certain ADAMs may participate in constitutive
shedding while others only in stimulated shedding; an example of the
latter is the shedding of ErbB ligands mediated by phosphorylation of
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β) [12]. In addition, ADAM10 and TACE/ADAM17 can be induced to
shed different ligands when cells are treated with phorbol 12-
myristate 13-acetate (PMA), suggesting a role for protein kinase C in
the activation of these enzymes [10]. The mechanism underlying
ADAMprotein activation is still far from elucidated. Some studies have
suggested that TACE/ADAM17 activity could involve the activation of
p38 MAPK, extracellular regulated kinases (ERK1/2) and PKC [4,6]. In
fact, TACE/ADAM17 has been shown to be phosphorylated by ERK at
threonine 735, which is associated with protein kinase C-regulated
TrkA cleavage [13].
Etoposide, along with cisplatin and bleomicyn, are drugs widely
used in the treatment of testicular cancer. We have shown that a
single dosis of etoposide in pubertal rats induces an increase in the
apoptosis of spermatocytes, along with p53 stabilization [14]. In order
to better study the mechanisms underlying etoposide action upon
germ cells, we used an in vitro model of germ cells with two
established cell lines: GC-1 spg and GC-2 spc, which have been
successfully used before as germ cell models [15,16].
In this work we show that etoposide induces apoptosis and
upregulation of ADAM10 and TACE/ADAM17 in GC-1 and GC-2 cells.
In addition, we show that pharmacological inhibitors of ADAM10 and
TACE/ADAM17 prevent the apoptosis induced by etoposide.
2. Materials and methods
2.1. Cell lines
Germ cell-1 spg (GC-1) and germ cell-2 spc (GC-2) were
purchased from the American Type Culture Collection (Rockville,
MD). GC-1 was originally created by Hofmann et al. to study the
process of germ cell differentiation [17,18]. Preleptotene spermato-
cytes from 6-week-old BALB/c mice were transformed using the SV40
virus's large T antigen. GC-1 cells have been characterized as being in a
stage between spermatocytes and spermatogonia. GC-2 was obtained
by cotransfecting with SV40 virus' large T antigen and a plasmid
carrying a mutant form of the gene encoding p53 (trp53), a
transcription factor involved in cell cycle regulation [17]. Previous
studies have shown that when grown at 37 °C they express several
markers characteristic of meiotic spermatocytes. Thus, these two cell
lines make an appropriate in vitro model for spermatogenesis.
GC-1 and GC-2 were cultured at 37 °C in a 5% CO2 atmosphere, in
Dulbecco modiﬁed Eagles media (DMEM; Life Technologies, Carlsbad,
CA) containing 4.5 g/L glucose, L-glutamine, 110 mg/L sodium
pyruvate, pyridoxine hydrochloride, and supplemented with 10%
fetal bovine serum and 100 U/ml penicillin-streptomycin. Cells were
grown up to 60-70% of conﬂuence and then etoposide (50–100 μM)
alone or in addition to ADAM inhibitors were administered and
apoptosis was evaluated at 0 (Control), 3, 6, 12, 24 and 36 h after drug
treatment.
2.2. Chemicals and antibodies
Etoposide and TAPI-0 were purchased from Merck (Darmstadt,
Germany). Rabbit polyclonal antibodies against TACE/ADAM17 were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The
monoclonal mouse antibody against β-actin was purchased from
Sigma (St Louis, MO) and the mouse monoclonal antibody against
ADAM10 was purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Anti-rabbit and anti-mouse UltraVision Detection Systems were
obtained from LabVision (Fremont, CA). The GI254023X and
GW280264X inhibitors were synthesized as described before
[19,20]. Etoposide, TAPI-0, GI254023X or GW280264X were ﬁrst
dissolved in DMSO and stored a 4 °C.Working solutions weremade by
diluting the stock solution in the cell culture medium.2.3. Protein extraction and Western blot
Protein extraction was performed by homogenizing cells in buffer
A (1% Triton X-100, NaCl 1 M, EDTA 1 mM, PMSF 10 mg/ml, Tris–HCl
20 mM pH 7.0) and then centrifuging for 10 min at 9300g. The
samples were run on a 12% polyacrylamide gel (SDS-PAGE) under
reducing and denaturing conditions, and then transferred to nitro-
cellulose at 30 V overnight or 100 V for 1.5 h. The nitrocellulose
membrane was blocked with 4% non-fat milk in PBS, pH 7.4, and then
incubated overnight at 4 °C with anti-ADAM17 (0.5 μg/ml), anti-
ADAM10 (0.2 μg/ml), or anti-β-actin (0.9 μg/ml) antibodies. After
extensive washing with PBS plus 0.05% Tween 20 (PBS-Tween), the
membrane was incubated with a secondary antibody conjugated to
peroxidase (KPL, Gaithersburg, Maryland) diluted 1:3,000 in PBS-BSA
for 1 h at room temperature. Protein bands were revealed using the
Super SignalWest Pico chemiluminescent substrate (Pierce, Rockford,
IL). Bands obtained were analyzed by measuring the pixels with
Adobe® Photoshop 7.0 (Adobe System Incorporated, USA), and
normalizing to β-actin levels.
2.4. TUNEL analysis
Apoptotic fragmentation of DNA was evaluated by TUNEL analysis
(Dead End System; Promega, Madison, Wis.). Cells were grown onto
coverslips and then ﬁxed with 1% paraformaldehyde for 15 min. The
assay was performed according to the manufacturer´s protocol.
Samples were observed under phase contrast and ﬂuorescence
microscopy (Optiphot-2, Nikon, Japan) by using ﬁlters for wave-
lengths at 460–500 nm (excitation) and 510–560 nm (barrier).
Micrographs were taken with a digital camera (CoolPix 4500, Nikon,
Japan).
2.5. Apoptosis and cell cycle analysis
To analyze cell cycles, the cell suspension in KHB solution was
pelleted and ﬁxed in ice-cold 70% ethanol overnight. As described by
Riccardi [21], on the day of analysis the cells were pelleted and
washed once with PBS. The pellet was then dissolved in a cell cycle
buffer containing 0.1% sodium citrate, 0.3% Triton X-100 (both Sigma-
Aldrich Co.), 50 μg/ml propidium iodide and 50 μg/ml RNase A (both
Invitrogen Corporation) dissolved in distilled water. The samples
were then analyzedwithin tenminutes of buffer addition in a BD FACS
Canto Flow Cytometer; 10,000 gated events were acquired. All date
were analyzedwith software FCS express V2.0 (De Novo Software, Los
Angeles, CA).
2.6. RT-PCR
Total RNA of decapsulated testes was isolated using TRIzol-
Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's
recommendations. Total RNA was quantiﬁed, and after conﬁrmation
of its integrity, cDNA was generated from 1 μg of RNA using random
primers and SuperScript II Reverse Transcriptase (Invitrogen, Carls-
bad, CA). The cDNA obtained was ampliﬁed by a polymerase chain
reaction (PCR) of 30 cycles using Taq polymerase (Fermentas) in 50 μl
of incubationmixture. Several primer sets were used to obtain the PCR
products: ADAM10 forward 5'-CCTACGAATGAAGAGGGAC-3' and
reverse 5'-A TCACAGCTTCTCGTGTTCC-3'; ADAM17 forward 5'-
GTTGGTGAGCCTGACTCTA-3' and reverse 5'-CCTCTTGTGGA-
GACTTGA-3'; GAPDH forward 5'-TCCACCACCCTGTTGCTGTA-3' and
reverse 5'-ACCACAGTCCATGCCATCAC-3' under the same aforemen-
tioned conditions. Aliquots of the PCR products were run in a 1%
agarose gel and then stained with 0.1 μg/ml ethidium bromide. Bands
obtained were analyzed by measuring the pixels with Adobe®
Photoshop CS3 (Adobe System Incorporated, USA), and normalizing
to GAPDH mRNA levels.
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For mean comparisons, we used analysis of variance (ANOVA).
When the ANOVA test showed statistical differences, the Student–
Newman–Keuls (SNK) test was used to discriminate between groups.
The Student's t-test was used for comparison of frequencies. Statistical
signiﬁcance was deﬁned as pb0.05 [22].
3. Results
First, we characterized the response of GC-1 and GC-2 cells to
etoposide. Cells were cultured with 100 μM etoposide and apoptosis
was analyzed at different time points. GC-1 cells cultured for 18 h
with etoposide showed many round structures resembling apoptoticFig. 1. Etoposide induces apoptosis in GC-1 cells. (A) Detachment and morphology changes o
show TUNEL staining of cells at the same time points indicated in the contrast phase micro
different time points. The horizontal bar shows the gate of subG1 (apoptotic) cells. (C) The
different time points of GC-1 cells treated with 100 μMetoposide, (D) Graph showing the per
concentrations of etoposide (**pb0.01, ***pb0.001). Bars 50 μm.bodies, and incubation for longer periods of time showed clear
evidence of cell detriment (Fig. 1A). TUNEL analysis showed positive
staining in many cells, suggesting apoptosis induction after etoposide
treatment (Fig. 1A, insert). In order to better evaluate apoptosis we
analyzed cell cycles at different points of time, and determined the
percentage of cells at the subG1 stage, which is a well-recognized
parameter of apoptosis (Fig. 1B).To avoid individual variation
between experiments, results were expressed as the ratio of change
in relation to control cells (without etoposide). Results showed that
from 3 to 12 h of incubation, there was a slight but non-signiﬁcant
increase in apoptosis. However, 18 h after etoposide addition,
apoptosis increased almost four times, and then up to seven times
in cells treated for 36 h, an effect that was concentration-dependent
(Fig 1C, D). Etoposide-induced apoptosis in GC-2 cells showed af GC-1 cells after incubation with 100 μM etoposide at different time points. The inserts
photograph. (B) Flow cytometry analysis of GC-1 incubated with 100 μM etoposide at
graph shows the ratio of change in apoptosis, relative to the starting point (t=0), at
centage of the subG1 (apoptotic) population of GC-1 cell cultured for 24 hwith different
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12 h after drug addition (Fig. 2A–C). We did not perform analyses at
longer periods of time since only a few cells looked viable and
remained attached to the culture dish. This effect was also
concentration-dependent (Fig. 2D). It has been shown that GC-2
cells express a temperature-sensitive mutant of p53: the mutant p53
protein is fully active at 32 °C, only partially active at 37 °C, and
completely inactive at 39 °C. We thought that this condition might
inﬂuence etoposide-induced apoptosis. However, we observed that
apoptosis induced by etoposidewas equally effective either at 32 °C or
37 °C (data not shown). Since GC-1 cells were grown at 37 °C we
decided to perform all experiments at 37 °C with both cell lines. Thus,
etoposide induced apoptosis in both cell lines, although at different
time points.
Next, we evaluated protein and mRNA levels of ADAM10 and
TACE/ADAM17 in GC-1 and GC-2 cells at different time points after
etoposide incubation. Results showed that in GC-1 cells cultured with
100 μM etoposide, mRNA levels of ADAM10 and TACE/ADAM17Fig. 2. Etoposide induces apoptosis in GC-2 cells. (A) Detachment and morphology changes o
show TUNEL staining of cells at the same time points indicated in the contrast phase micro
different time points. The horizontal bar shows the gate of subG1 (apoptotic) cells. (C) The
different time points of GC-2 cells treated with 100 μM etoposide. (D) Graph showing the
different concentrations of etoposide (**pb0.01, ***pb0.001). Bars 50 μm.peaked 12 h after etoposide addition, whereas protein levels (the
mature forms of both enzymes) signiﬁcantly increased after 18 h
(Fig. 3A, B). On the other hand, mRNA levels of ADAM10 in GC-2 cells
signiﬁcantly increased 6 h after etoposide addition and then steadily
declined (Fig. 4A, B). TACE/ADAM17 mRNA levels slightly declined
from zero to 9 h after treatment (Fig. 4A). ADAM10 and TACE/
ADAM17 protein levels in GC-2 cells increased slightly but signiﬁ-
cantly 12 h after etoposide addition (Fig. 4A, B).
Finally, we studied if TACE/ADAM17 was indeed associated with
etoposide-induced apoptosis in GC-1 and GC-2 cells. To this end, we
incubated GC-1 cells for 24 h and GC-2 cells for 12 h in the presence of
100 μM etoposide alone or in combination with 300 nM TAPI-0a well-
known speciﬁc TACE/ADAM17 inhibitor. Results showed that TAPI-0
alone did not induce apoptosis related morphological changes in GC-1
or GC-2 cells (Figs. 5A, 6A). However, when GC-1 cells were treated
with 100 μM etoposide in combination with 300 nM TAPI-0, the
majority of cells had unaltered (viable) morphology after 24 h of
incubation, and the rate of apoptosis was signiﬁcantly lower thanf GC-2 cells after incubation with 100 μM etoposide at different time points. The inserts
photograph. (B) Flow cytometry analysis of GC-2 incubated with 100 μM etoposide at
graph shows the ratio of change in apoptosis, relative to the starting point (t=0), at
percentage of the subG1 (apoptotic) population of GC-2 cells cultured for 12 h with
Fig. 3. Etoposide induces the expression of ADAM10 and TACE/ADAM17 in GC-1 cells. GC-1 cells were incubated with 100 μMetoposide for 18 h and subsequently mRNA and protein
levels were measured at different time points. (A) RT-PCRs of ADAM10 and TACE/ADAM17 at the indicated time points after etoposide incubation. GADPH was used as a loading
control. The ﬁgure shows two independent experiments. The graph shows the average intensities of ADAM10 and TACE/ADAM17 bands relative to GADPH, at the indicated time
points. Both mRNAs signiﬁcantly increased 12 h after incubation with etoposide. (B) Western blots of ADAM10 and TACE/ADAM17 of GC-1 cells at different time points following
100 μM etoposide incubation. The Western blots show the mature forms of both proteins. The graph shows the intensity of each band relative to β-actin, as a loading control. Both
proteins signiﬁcantly increased 18 h after treatment (**pb0.01, n=3).
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discriminate between the relative contribution of ADAM10 and
TACE/ADAM17, we used other pharmacological inhibitors. Two
different inhibitors for ADAMs had been described prior to this
work: compound GW280264X blocks both ADAM10 and TACE/
ADAM17 with comparable IC50 values, whereas compound
GI254023X has 100-fold higher speciﬁcity for ADAM10 [19,23].
These inhibitors have been used to study the role of TACE/ADAM7
and ADAM10 in other systems [19,20,24]. We found that 5 μM
GI254023X signiﬁcantly prevented apoptosis induced by etoposide,
and that 5 μM GW280264X showed an even higher inhibition of
apoptosis than GI254023X in GC-1 cells (Figs. 5D). When GC-2 cells
were treated with etoposide in combinationwith 300 nM TAPI-0, only
a few attached cells were observed after 12 h of culture, a similar
situation as with etoposide alone (Fig. 6A). Flow cytometry analysis
conﬁrmed that TAPI-0 did not signiﬁcantly change the apoptosis rate
in GC-2 cells in combination with 100 μM etoposide (Fig. 6B, C).
Interestingly, 5 μM of GW280264X and GI254023X signiﬁcantly
decreased etoposide-induced apoptosis to a similar extent (Fig. 6D).
Therefore, our results show that ADAM10 and TACE/ADAM17 in GC-1,
but only ADAM10 in GC-2 cells, appear to be involved in etoposide-
induced apoptosis.4. Discussion
Matrix metalloproteinases play a key role in many biological
processes, including cancer. Here we show that etoposide induces
upregulation of two metalloproteinases: ADAM10 and TACE/
ADAM17. Even more, we showed that ADAM10, and more impor-
tantly TACE/ADAM17, are components of the machinery triggered by
etoposide to induce apoptosis in germ cells.
It has been shown that etoposide induces apoptosis mainly in
spermatocytes in pubertal rat testes [14,25,26]. Here we show that
etoposide induces apoptosis in GC-1 and GC-2 cell lines, which have
been used previously as a germ cell model to test apoptosis after
genotoxic stimulus [15]. Our results clearly showed that, in GC-1 cells
upregulation of protein levels of ADAM10 and TACE/ADAM17 (18 h
after removal of etoposide) was coincident with the increase in
apoptosis observed in this cell line. On the contrary, ADAM10 and
TACE/ADAM17 protein levels were upregulated 12 h after incubation in
GC-2 cells, even though apoptosis was observed after 6 h of etoposide
incubation. Thus, the time course of apoptosis is coincident with the
upregulation of both metalloproteinases after etoposide treatment.
Despite the fact that both cells lines were derived from germ cells, they
behave differently in response to etoposide treatment. GC-1 cells show
Fig. 4. ADAM10 and TACE/ADAM17 protein and mRNA levels in etoposide-treated GC-2 cells. GC-2 cells were incubated with 100 μM etoposide for 12 h and subsequently the mRNA
and protein levels were measured at different time points. (A) RT-PCRs of ADAM10 and TACE/ADAM17 at the indicated time points after etoposide treatment. GADPH was used as a
loading control. The ﬁgure shows two independent experiments. The graph shows the intensities of ADAM10 and TACE/ADAM17 bands relative to GADPH, at the indicated time
points. (B) Western blots of ADAM10 and TACE/ADAM17 of GC-2 cells at different time points following 100 μM etoposide incubation. Only mature forms were visualized by
Western blots. The graph shows the intensity of each band relative to β-actin, as a loading control. Both proteins signiﬁcantly increased 12 h after treatment (**pb0.01, n=3).
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spermatocytes, but GC-2 cells, which were derived from GC-1, express
markers of primary spermatocytes. It is possible that these differences
may be related to p53, which is mutated in GC-2 cells [17,18]. This
observation is partially supported by the fact that under our conditions
(culture at 37 °C) p53 is not fully active, but is fully active in GC-1 cells.
Thus, p53 could change the responsiveness to etoposide and could
induce the upregulation of ADAM proteins. In fact, we have shown that
etoposide induced germ cell apoptosis in vivo and in vitro (using GC-2
cells) is dependent uponp73 activation, a closely relatedmember of p53
[27]. Thus, it seems that p73, alongwith p53, are important regulators of
germ cell apoptosis. It remains to be shownwhether p53 and/or p73 can
regulate ADAMs gene expression in physiological conditions or after
genotoxic treatment.
We show here that pharmacological inhibition of TACE/ADAM17
(using TAPI-0) was able to prevent apoptosis induced by etoposide in
GC-1, but not in GC-2 cells. TAPI-0 inhibits TACE/ADAM17-dependent
shedding of different membrane bound proteins. However, it has also
been shown that extracellular shedding in cells harboring aninactivating mutation for TACE/ADAM17 is prevented by TAPI-0,
suggesting that it could inhibit other related metalloproteinases,
probably ADAM10 [28]. In this work we used two other ADAM
inhibitors, which have been previously shown to be useful to
elucidate ADAM-dependent ectodomain shedding [19,20]. The com-
pound GW280264X blocks both ADAM10 and ADAM17 with
comparable IC50 values, whereas compound GI254023X has 100-
fold higher speciﬁcity towards ADAM10. We found that GI254023X,
which inhibits ADAM10, signiﬁcantly prevents etoposide-induced
apoptosis in both cells lines, suggesting a role for ADAM10 in this
process. However, GW280264X prevented etoposide-induced apo-
ptosis in GC-1 to an even higher extent than GI254023X, which
suggests that TACE/ADAM17 has an important role in apoptosis in this
cell line. Thus, our results that ADAM10 and ADAM17 are important in
etoposide induced apoptosis in GC-1 and GC-2 cell lines. This is the
ﬁrst report showing that apoptosis induced by a genotoxic stimulus is
mediated by an ADAM metalloproteinase.
Our results show that etoposide induces a transient upregulation
of TACE/ADAM17 and ADAM10 mRNA in both cell lines. These results
Fig. 5. Pharmacological inhibitors of ADAM10 and TACE/ADAM17 prevent etoposide-induced apoptosis in GC-1 cells. GC-1 cells were incubated with 100 μMetoposide for 24 h, with
or without 300 nM TAPI-0. (A) Incubation with TAPI-0 alone did not induce detachment or morphological changes. Cultures treated with etoposide in combination with TAPI-0
showed an increased number of cells compared to the cultures with etoposide alone. (B) Cell cycle analysis of GC-1 cells under different conditions. Apoptotic cells are readily
recognized as subG1 cells, horizontal bar in each graph. (C) Apoptosis was evaluated as the ratio of changes in subG1 cells, relative to control cells (without etoposide). TAPI-0 alone
did not have any effect upon cell survival; however, it was able to signiﬁcantly prevent apoptosis in cells treated with etoposide. (D) Effects of speciﬁc metalloprotease inhibitors
GW280264X (GW, equally speciﬁc for ADAM17 and ADAM10) and GI254023X (GI, 100-fold more speciﬁc for ADAM10) on etoposide-induced apoptosis (**pb0.01, n=3). Bars
50 μm.
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regulated. Hence, it is possible that GC-1 cells regulate the protein
levels of both metalloproteinases at the mRNA level. In GC-2 cells the
same seems to be true for TACE/ADAM17, but the mRNA levels of
ADAM10 slightly decline during the studied period. It has been shown
that ADAM10 and ADAM17 can be upregulated at the protein level by
activation of protein kinase C or 38 MAP kinase, extracellular
regulated kinase (ERK1/2), PKC and an increase in the concentration
of free intracellular calcium [4,6,29,30]. In particular, it has been
shown that p38 MAP kinase binds and interacts with the cytoplasmic
domain of TACE and phosphorylates it on Thr(735), which is required
for TACE-mediated ectodomain shedding [30]. Interestingly, it seems
that p38MAP kinase and PKC interact with different domainswith the
cytoplasmic domain of TACE/ADAM17 in order to promote L-selectin
shedding from mouse leucocytes [29]. On the other hand, ADAM10
protein levels could be increased by Ca(2+) inﬂux as well as be
stimulated by PMA under some conditions, suggesting that PKC
activation might be involved in ADAM10-mediated proteolysis
[10,31,32]. It has been shown that along with topoisomerase II
inhibition and DNA breaks promotion, etoposide induces activation of
PKC, p38 MAP kinase, and an increase of reactive oxygen species and
of the free intracellular calcium concentration [5,6,33,34]. Thus it is
possible that activation of PKC, ROS or p38 MAP kinase in etoposide-treated cells induces upregulation of TACE/ADAM17 and ADAM10 at
the protein level.
In conclusion, in this work we describe TACE/ADAM17 and
ADAM10 as new elements in the molecular pathway elicited by
etoposide to induce apoptosis in GC-1 and GC-2 cells. Etoposide, alone
or in combination with other anticancer drugs is widely used in the
treatment of several cancers, and it has several unwanted side effects.
GC-1 and GC-2 cell lines are a model of normal (not cancer) male
germ cells and the reported effect in this work might be similar to in
vivo conditions. It is possible that upregulation of metalloproteinases
such as ADAM17 or ADAM10 may be causing unwanted secondary
effects in normal viable cells in patients undergoing chemotherapy.
Thus, it remains to be determined whether etoposide elicits
upregulation of TACE/ADAM17 and ADAM10 in cancer cell lines as
well or only in normal viable germ cells.Acknowledgments
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Fig. 6. Pharmacological inhibitors of ADAM10 and TACE/ADAM17 prevent etoposide-induced apoptosis in GC-2 cells. GC-2 cells were incubated with 100 μMetoposide for 12 h, with
or without 300 nM TAPI-0. (A) GC-2 cells treated with etoposide plus TAPI-0 or with TAPI-0 alone showed a similar low number of cells after 12 h of culture. (B) Cell cycle analysis of
GC-2 cells in different conditions. Apoptotic cells are easily recognized as subG1 cells, horizontal bar in each graph. (C) Apoptosis was evaluated as the ratio of changes in subG1 cells,
relative to control cells (without etoposide). TAPI-0 did not modify the apoptosis rate and was not able to prevent apoptosis in cells treated with etoposide. (D) Effect of speciﬁc
metalloproteinase inhibitors GW280264X (GW, equally speciﬁc for ADAM17 and ADAM10) and GI254023X (GI, 100-foldmore speciﬁc for ADAM10) on etoposide-induced apoptosis
(**pb0.01, n=3). Bars 50 μm.
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